SLNO
Price
$62.74
Change
+$0.63 (+1.01%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
3.33B
28 days until earnings call
VRCA
Price
$4.43
Change
-$0.18 (-3.90%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
41.75M
32 days until earnings call
Interact to see
Advertisement

SLNO vs VRCA

Header iconSLNO vs VRCA Comparison
Open Charts SLNO vs VRCABanner chart's image
Soleno Therapeutics
Price$62.74
Change+$0.63 (+1.01%)
Volume$27.89K
Capitalization3.33B
Verrica Pharmaceuticals
Price$4.43
Change-$0.18 (-3.90%)
Volume$1.84K
Capitalization41.75M
SLNO vs VRCA Comparison Chart in %
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLNO vs. VRCA commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNO is a StrongBuy and VRCA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (SLNO: $62.74 vs. VRCA: $4.42)
Brand notoriety: SLNO and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNO: 59% vs. VRCA: 95%
Market capitalization -- SLNO: $3.33B vs. VRCA: $41.75M
SLNO [@Biotechnology] is valued at $3.33B. VRCA’s [@Biotechnology] market capitalization is $41.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNO’s FA Score shows that 0 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • SLNO’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNO’s TA Score shows that 6 TA indicator(s) are bullish while VRCA’s TA Score has 5 bullish TA indicator(s).

  • SLNO’s TA Score: 6 bullish, 2 bearish.
  • VRCA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than VRCA.

Price Growth

SLNO (@Biotechnology) experienced а +4.36% price change this week, while VRCA (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

SLNO is expected to report earnings on Nov 05, 2025.

VRCA is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.33B) has a higher market cap than VRCA($41.8M). SLNO YTD gains are higher at: 39.577 vs. VRCA (-36.857). VRCA has higher annual earnings (EBITDA): -38.54M vs. SLNO (-176.1M). SLNO has more cash in the bank: 287M vs. VRCA (15.4M). VRCA has less debt than SLNO: VRCA (38.9M) vs SLNO (52.8M). SLNO has higher revenues than VRCA: SLNO (32.7M) vs VRCA (14.7M).
SLNOVRCASLNO / VRCA
Capitalization3.33B41.8M7,976%
EBITDA-176.1M-38.54M457%
Gain YTD39.577-36.857-107%
P/E RatioN/AN/A-
Revenue32.7M14.7M222%
Total Cash287M15.4M1,864%
Total Debt52.8M38.9M136%
FUNDAMENTALS RATINGS
SLNO vs VRCA: Fundamental Ratings
SLNO
VRCA
OUTLOOK RATING
1..100
724
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNO's Valuation (60) in the Medical Specialties industry is in the same range as VRCA (91) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

SLNO's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew somewhat faster than VRCA’s over the last 12 months.

SLNO's SMR Rating (98) in the Medical Specialties industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

SLNO's Price Growth Rating (65) in the Medical Specialties industry is in the same range as VRCA (65) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that SLNO’s stock grew similarly to VRCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNOVRCA
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRLIX45.26N/A
N/A
Voya Russell Large Cap Index Port A
JORCX20.01N/A
N/A
Janus Henderson Global Select C
RSSRX27.14N/A
N/A
Victory RS Select Growth R6
USBOX25.38N/A
N/A
Pear Tree Quality Ordinary
OAZMX164.86-0.75
-0.45%
Oakmark R6

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.01%
BRNS - SLNO
56%
Loosely correlated
-4.55%
NUVL - SLNO
40%
Loosely correlated
+1.78%
SYRE - SLNO
39%
Loosely correlated
+10.36%
VRDN - SLNO
38%
Loosely correlated
+1.71%
GRCE - SLNO
38%
Loosely correlated
-0.66%
More